CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 160,000 shares at an average $1.29 ($206,023)
- 4 Open-market buy 10% owner bought 120,000 shares at an average $1.35 ($162,255)
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 4 Open-market sale 10% owner sold 250 shares at $1.88 ($469)
- 4 Open-market sale 10% owner sold 278 shares at $1.89 ($525)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 4 Open-market buy 10% owner bought 20,000 shares at an average $1.60 ($32,000)
- 4 Open-market buy President, CEO, COB bought 2,200 shares at $1.70 ($3,740)
- 8-K Event Shareholder vote results
- 4 Open-market buy 10% owner bought 2,500 shares at an average $2.07 ($5,165)
- 4 Open-market buy President, CEO, COB bought 800 shares at $1.53 ($1,226)
- 4 Open-market buy President, CEO, COB bought 2,887 shares at $1.96 ($5,659)
- 4 Open-market buy VP of Research and Development bought 4,954 shares at $2.22 ($10,998)
- 424B5 Offering Prospectus
Page 7 of 38 · 755 filings